Ivana Cattaneo: One week ago five new global teams have been selected to receive up to $25m each over five years to tackle some of cancer’s toughest challenges

Ivana Cattaneo, Executive Director Therapeutic Area Advocacy and Precision Medicine at Novartis, shared the following on LinkedIn:

“One week ago five new global teams have been selected to receive up to $25m each over five years to tackle some of cancer’s toughest challenges: Cancer inequities, Early-onset cancers, Solid tumours in children and T-cell receptors.
Here the five new teams and here (some of) the advocacy panel experts I have the pleasure to work with in Cancer Grand Challenges.

Yelak Biru, Joya Delgado Harris, Dirk Hellrung (credit to Patrick Harrison for the picture and to Andrea Delgado Garcia for the leadership in steering our work).”

Source: Ivana Cattaneo/LinkedIn